Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

NIH sponsors Kosan Biosciences' research in immunology and CNS diseases

June 3, 1997

No Comments

Xenova and Warner-Lambert enter further drug discovery collaboration

June 2, 1997

No Comments

Integrin recognition surface identified

May 29, 1997

No Comments

PharmaSciences and BTG extend license for hydrogel drug delivery technology

May 27, 1997

No Comments

Scriptgen and Lilly enter drug discovery collaboration

May 23, 1997

No Comments

RPR and Stanford enter research agreement for drug discovery and gene therapy

May 23, 1997

No Comments

DepoMed seeks alliances for drug delivery systems

May 21, 1997

No Comments

HemaSure stops development of SteriPath

May 20, 1997

No Comments

LXR and Oxford Asymmetry enter drug discovery collaboration

May 14, 1997

No Comments

Sugen researchers discover co-crystal of FGF TK

May 14, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Drug design, drug delivery and technologies, BioWorld Science
RSS

NIH sponsors Kosan Biosciences' research in immunology and CNS diseases

Xenova and Warner-Lambert enter further drug discovery collaboration

Integrin recognition surface identified

PharmaSciences and BTG extend license for hydrogel drug delivery technology

Scriptgen and Lilly enter drug discovery collaboration

RPR and Stanford enter research agreement for drug discovery and gene therapy

DepoMed seeks alliances for drug delivery systems

HemaSure stops development of SteriPath

LXR and Oxford Asymmetry enter drug discovery collaboration

Sugen researchers discover co-crystal of FGF TK

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Drug design, drug delivery and technologies, BioWorld Science RSS

Drug design, drug delivery and technologies, BioWorld Science
RSS